3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
76
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Burkitt Lymphoma
17
Recurrence
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Neoplasms, Plasma Cell
5
Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Immunoglobulin Light-chain Amyloidosis
5
Smoldering Multiple Myeloma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Leukemia
4
Neoplasm Metastasis
3
Down Syndrome
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Waldenstrom Macroglobulinemia
2
Prostatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma, B-Cell
2
Lung Neoplasms
2
Leukemia, Hairy Cell
2
Hodgkin Disease
2
Fatigue
2
Brain Neoplasms
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
brincidofovir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
Calcium Dobesilate
×
1 year
×
Clear all
No trials found.